Post-sleeve Gastrectomy Gastroesophageal Reflux Disease Prediction
Recruiting
Prediction of Post-laparoscopic Sleeve Gastrectomy Gastroesophageal Reflux Disease With an Endolumenal Functional Lumen Imaging Probe (EndoFLIP)
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Adult patients \> 18 years * BMI 30 or greater kg/m2 * Participants can give a consent to the procedure * Participants have no contraindications to LSG (gastric ulceration) Exclusion Criteria: * Participants who have LA grade C or D esophagitis, Barrett mucosa or peptic stricture. * Patients who have evidence of a major motility abnormality defined by the Chicago classification version 3.0 (achalasia, absent contractility, esophagogastric junction outflow obstruction, distal esophageal spasm, or hypertensive peristalsis) * Patients with hiatal hernia \> 3 cm * Patients with previous esophageal or stomach surgery
About the study
Researchers are trying to identify predictors for gastroesophageal reflux disease after sleeve gastrectomy.
What is being tested
- EndoFLIP measurement (device)
Sponsor: Mayo Clinic · Participants: 200 · Started: Feb 1, 2021
Contact the study team
- Elizabeth Lemke · Phone: 5072663317
Official record on ClinicalTrials.gov — NCT04411823
Locations in the U.S.
| Minnesota | Mayo Clinic in Rochester, Rochester |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.